Partner Headlines - IRWD

  1. Allergan Outlook Improves On Good Trial For Colon Drug: Credit ...

    Investors Business Daily
  2. Allergan Outlook Improves On Good Trial For Colon Drug: Credit ...

    Investors Business Daily
  3. Ken Fisher's Best Investments: Credicorp, Ambev, Tata Motors

    GuruFocus
  4. Benzinga's Top Initiations

    Benzinga
  5. US Stock Futures Edge Lower Ahead Of Earnings

    Benzinga
  6. Allergan Acquires Rights to Ironwood's CONSTELLA from Almirall ...

    Benzinga
  7. A Look at Steven Cohen's Investment in Ironwood Pharmaceuticals

    GuruFocus
  8. Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for ...

    Benzinga
  9. Ironwood Progresses sGC Stimulator Platform with Positive Top-Line ...

    Benzinga
  10. Benzinga's Top #PreMarket Gainers

    Benzinga
  11. Sucampo Stock Rebounds As Drug Gets Fast-Track Review

    IBD
  12. The World's Top 10 Financial Bloggers

    GuruFocus
  13. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  14. Ironwood Presents IW-9179 Phase IIa Data At American College ...

    Benzinga
  15. Ardelyx Bowel Drug Could Rival Actavis' Linzess

    IBD
  16. Markets Open Higher; VeriFone Profit Tops Street View

    Benzinga
  17. Benzinga's Top Downgrades

    Benzinga
  18. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  19. Ironwood Pharmaceuticals Announces $150M Proposed Public Offering ...

    Benzinga
  20. Mid-Day Market Update: Dow Tumbles Over 100 Points; Signature ...

    Benzinga
  21. Mid-Morning Market Update: Markets Mixed; Verizon Posts Q4 Profit

    Benzinga
  22. Weekly 3-Year Low Highlight: EXC, RVBD, IRWD, SHOS

    GuruFocus
  23. UPDATE: Cowen & Company Upgraded Ironwood Pharmaceuticals

    Benzinga
  24. Five-Year Lows: Singapore Airlines Limited, Gold Field Ltd., ...

    GuruFocus
  25. Stocks Hitting 52-Week Lows

    Benzinga
  26. Earnings Scheduled For January 15, 2013

    Benzinga
  27. Ironwood Starts Phase I Trial of Anti-Anxiety Drug in US

    Benzinga
  28. Weekly CEO Buys Highlight: GDOT, VOCS, PES, IRWD, ABR

    GuruFocus
  29. Ironwood Pharmaceuticals, Inc. (IRWD) CEO Peter M Hecht buys ...

    GuruFocus
  30. Ironwood and AstraZeneca Announce Linaclotide Collaboration for ...

    Benzinga
  31. Ironwood and Forest Announce FDA Approval of LINZESSTM

    Benzinga
  32. UPDATE: Cantor Fitzgerald Raises PT to $8 on Ironwood Pharmaceuticals; ...

    Benzinga
  33. Biotechs With Upcoming PDUFA Dates

    Benzinga
  34. UPDATE: Wedbush Downgrades Ironwood Pharmaceuticals; Lowers PT

    Benzinga
  35. Bank of America: Zelnorm vs. linaclotide

    Benzinga
  36. Ironwood Pharmaceuticals Announces Exercise of Over-Allotment ...

    Benzinga
  37. From Earlier: Ironwood Pharmaceuticals Prices Public Offering ...

    Benzinga
  38. Ironwood Pharmaceuticals Announces Proposed Public Offering of ...

    Benzinga
  39. Ironwood Pharmaceuticals and Bionomics Announce Collaboration, ...

    Benzinga
  40. European Patent Office Upholds Synergy Pharmaceuticals' Grant ...

    Benzinga
Trading Center